Skip to main content

New top story from Time: FDA Panel Greenlights First Single-Shot COVID-19 Vaccine, from Johnson & Johnson

https://ift.tt/3pZf3dk

The U.S. Food and Drug Administration’s (FDA) vaccine advisory committee earlier today (Feb. 26) voted unanimously to recommend Johnson & Johnson’s COVID-19 vaccine for emergency use authorization. While the FDA isn’t obligated to follow the committee’s advice, it generally does.

At the end of a full day of review and discussion of the company’s shot, all 22 voting members of the committee agreed that the vaccine was safe and effective enough to be used by the public. It’s the third vaccine that the group of independent experts has recommended, following Pfizer-BioNTech and Moderna. Unlike the two previous vaccines, J&J’s is a single shot, and can be shipped and stored under refrigerated, not frozen conditions, as the other two require.

The single dosing played a part in the committee’s decision. Logistically, vaccinating people one time is much easier than asking them to return for a second dose. “This was a relatively easy call,” Dr. Eric Rubin, editor in chief of the New England Journal of Medicine and professor at Harvard T.H. Chan School of Public Health, who voted to recommend the shot said during the discussion. “[The vaccine] clearly gets way over the bar of safety and efficacy, and it’s a single-dose vaccine.”

The committee members reviewed data presented by Janssen Pharmaceuticals, the J&J arm that developed the vaccine, as well as FDA scientists’ review of that data. Janssen’s vaccine uses a different technology than Pfizer-BioNTech and Moderna, which both relied on a new platform involving mRNA. Janssen’s vaccine, on the other hand, is made with a weakened cold virus that can’t cause disease, manipulated so that it carries the genes for making one of the key proteins of SARS-CoV-2, the virus that causes COVID-19. Once that viral protein is introduced to the body, human immune cells learn to recognize it as foreign and launch attacks against it.

In Janssen’s primary vaccine study, involving nearly 44,000 people, a single dose was found to be 66% effective in protecting people from moderate to severe COVID-19 disease. It was slightly less effective in protecting against new variants of the virus—against one that was first identified in South Africa, it was around 57%. Still, that protection met the threshold of 50% efficacy set by the FDA for granting emergency use authorization.

Committee members raised questions about how much of the immune response to the COVID-19 virus might be blunted by a response mounted against the weakened cold virus used as the delivery vessel, a well known effect using this vaccine platform. Such vaccines are also potentially less effective when boosted with additional shots since the body becomes tolerant to the weakened virus vector. However, Dr. Johan Van Hoof, managing director of Janssen Vaccines and Prevention, noted that tests on the company’s HIV vaccine candidate using similar technology have shown that people boosted with additional shots years after the first continued to generate strong immune responses that didn’t seem to be significantly affected by the weakened virus vector.

Many committee members raised questions about the company’s data showing that the vaccine produced a slightly lower response in terms of antibody levels against the virus among people over age 60, especially those with underlying health conditions—a group particularly vulnerable to COVID-19. However, Janssen studies found that these people still did not develop severe COVID-19 disease or need hospitalization compared to people getting placebo. In fact, the vaccine was 85% effective in protecting people from severe disease and overall there were only 21 deaths among the 44,000 people studied; five occurring among those who were vaccinated and the remainder among the placebo group. None of the deaths were considered related to the vaccine.

The FDA scientists did note in their review that some participants in the study did experience serious side effects, including tinnitus (ringing in the ears), clotting and hives—which could be related to the vaccine and are worth further follow up. However, these were rare, and overall the vaccine was safe with most who reported side effects having only mild to moderate reactions including headache, chills and muscle aches.

The other question that continued to pop up during the day-long discussion focused on whether Janssen’s vaccine is really a one-shot vaccine or whether it, like the Pfizer-BioNTech and Moderna vaccines, actually requires a two-shot regimen. While the data the company submitted were from a trial in which participants were given only a single dose, the company is currently conducting another study of 30,000 people who will receive two doses of the shot—to see if an additional booster will raise immune responses even further.

If two doses prove to be more effective, it will raise a tricky question about what to do with people who might receive the single dose shot in coming weeks or months, should the one-dose regimen be authorized. Van Hoof argues that this is a question worth putting off for later, given the urgency of the current situation. “We feel the results of the study of our single dose showed high efficacy against severe disease, especially hospitalizations and death, and in a situation of mass vaccination programs, our regimen is extremely well positioned to be used during the outbreak,” he said.

Then of course there is the question of the recently identified genetic variants of SARS-CoV-2 that appear even more infectious than the original virus. Pfizer-BioNTech and Moderna did not have to deal with that when they submitted their requests back in December 2020, but the companies have since conducted additional tests that have shown that their vaccines remain effective in protecting against the major new mutations. Janssen’s submission to the FDA included some early data on the efficacy of its vaccine against the new variants, and Van Hoof told the committee that the company plans to continue genetic sequencing virus from people in the company’s trials if they test positive and will include that information in the final request for full approval which could come later this year. In the meanwhile, Janssen—like Pfizer-BioNtech and Moderna—is already working on a next-generation vaccine specifically targeting the new variants that could begin human testing by summer.

The FDA committee’s decision to recommend the Janssen shot now goes to the agency. If the FDA agrees to grant the emergency use authorization, the next step will be for the Centers for Disease Control and Prevention’s immunization committee to work out details of who should be vaccinated with the new shot, and the logistics for how to make that happen. That CDC committee will also likely make decisions about whether certain groups should be targeted to receive this specific vaccine, and what advice to provide vaccinators when people ask about whether they will need a second shot. That information won’t be available until Janssen completes its two-dose study in coming months.

Comments

Popular posts from this blog

Bihar: Stages collapse during Congress rallies in Darbhanga, West Champaran https://ift.tt/37QFnks

The stage on which Congress candidate from Jale assembly seat, Mashkoor Ahmad Usman was addressing a rally broke and collapsed in Bihar's Darbhanga on Thursday. In a similar incident, another stage collapsed and took down party leaders Imran Pratapgarhi and Akhilesh Singh along with several party workers who were on the dias, during a Congress rally at Bagahi Deoraj in Champaran.

Powered Scooters Charge City’s Transportation Recovery

Powered Scooters Charge City’s Transportation Recovery By Jason Hyde The SFMTA is releasing its next round of Powered Scooter Share permits on July 1. Scooters remain a sustainable mode of travel and a complement to Muni and public transit service as the city recovers from the pandemic and San Franciscans begin to travel more. The SFMTA’s Powered Scooter Share Program is essential in ensuring that shared scooter operations support the city’s economic recovery in a safe, sustainable, and equitable way.  The SFMTA received four submittals for the permit program and will issue permits to two operators : Spin and Lime. Permits will be in effect for a one-year term, with the option to extend for another year at the discretion of the SFMTA based on compliance with various program metrics. While the new permit program does not set a limit on the number of scooters each operator may deploy, it does limit the overall citywide fleet size at 10,000. Starting at a base of 2,000 scooters...

New Muni Service Changes Start Saturday, August 19

New Muni Service Changes Start Saturday, August 19 By Clive Tsuma 28R 19th Avenue will run on weekdays between 7 a.m. and 7 p.m. starting Monday, August 21.  Back to School  With SFUSD students returning to school August 16, many families who rely on Muni to get to school will see service increase after school as part of the new schedule. Because Muni vehicles often become crowded during morning peak hours and sometimes pass up stops when there is not enough room for more riders, families are encouraged to plan their trips ahead of time and hop on Muni early to make sure students get to school on time.  With every public school in the San Francisco Unified School District being served by at least one Muni route , students can expect extra Muni service on the first day of the school this fall and continue providing service throughout the school year. While the Muni service changes won’t be implemented until August 19, school tripper service will be offered starting Au...

Plan Your Next Golden Gate Park Trip with Muni

Plan Your Next Golden Gate Park Trip with Muni By Eillie Anzilotti   A map of San Francisco showing Muni lines that offer direct service to Golden Gate Park, including: The 18 46th Avenue, the 29 Sunset, the 5 Fulton and 5R Fulton Rapid, the N Judah, the 44 O’Shaughnessy, the 33 Ashbury/18th Street, the 7 Haight/Noriega, the 43 Masonic and the 28 19th Avenue. Around each bus route shown on the map, a red zone shows the range within 1,000 feet of a stop, orange shows within 2,000 feet of a stop, and yellow shows within 3,000 feet. Here’s a fun fact: 70% of San Franciscans are within a 15-minute walk of a transfer-free Muni ride to the largest public space in our city: Golden Gate Park.   Especially as COVID-19 has heightened the importance of outdoor recreation and park access, SFMTA has made efforts to update Muni service to get people to Golden Gate Park. As of now, ...

India reports first 6 cases of new coronavirus strain after UK returnees test positive https://ift.tt/3pA0T2j

India on Tuesday reported the first six cases of the new coronavirus strain after six people who had returned from the United Kingdom were tested positive for the new UK variant genome. According to the details, the new coronavirus strain cases were reported from Hyderabad, Pune and Bangalore. Samples of 3 UK returnees were tested and found positive for the new UK strain in NIMHANS, Bengaluru. The other two cases were tested at the Centre for Cellular and Molecular Biology, Hyderabad; while the last case was tested at the National Institute of Virology, Pune.

The Golden Gate Park Shuttle: Back and Better than Ever!

The Golden Gate Park Shuttle: Back and Better than Ever! By Eillie Anzilotti Over the months of outreach that the SFMTA and our colleagues at the San Francisco Recreation and Park Department conducted for the Golden Gate Park Access & Safety Program , we heard a lot of feedback on the park shuttle. Specifically, that it needed some TLC.   Now, the Golden Gate Park free shuttle is getting the major overhaul it deserves. This past weekend, Rec & Park and the SFMTA began rolling out some key improvements to the shuttle—starting with expanded service, a longer and more connected route, more stops, and shorter wait times. These upgrades were informed by feedback from the numerous older and senior residents and members of the disability community, and will create a more accessible, reliable, and enjoyable experience of Golden Gate Park and its cultural institutions.  Here are some more details on all the improvements:   New weekday service from noon t...

अगर मैंने आत्महत्या की तो लोगों को पता होना चाहिए किसकी वजह से की - फूटकर रोते दिखे विकास गुप्ता

सुशांत सिंह राजपूत की आत्महत्या हर किसी को एक गहरा सदमा दे गई है और अब सुशांत के करीबी दोस्त विकास गुप्ता ने एक वीडियो में अपनी आपबीती सुनाई है। विकास इस वीडियो में बेहद टूटे हुए नज़र आ रहे हैं from टेलीविजन की खबरें | Television News in Hindi | TV Serials Update in Hindi – FilmiBeat Hindi http:/hindi.filmibeat.com/television/vikas-gupta-reveals-people-want-him-to-commit-suicide-cries-his-heart-out-for-sushant-singh-rajput-090284.html?utm_source=/rss/filmibeat-hindi-television-fb.xml&utm_medium=23.213.205.12&utm_campaign=client-rss

FOX NEWS: Ohio amusement park shut down after multiple fights break out Kings Island in Mason, around 20 miles north of Cincinnati, closed down 30 minutes early Saturday night after several fights among teenagers occurred, reports suggest.

Ohio amusement park shut down after multiple fights break out Kings Island in Mason, around 20 miles north of Cincinnati, closed down 30 minutes early Saturday night after several fights among teenagers occurred, reports suggest. via FOX NEWS https://ift.tt/3wsn8uI

FOX NEWS: UK neighbors cut tree in half over bird poop dispute: ‘We were absolutely distraught’ Pictures of the odd tree in Sheffield, U.K., have been posted online and have been turned into memes on social media.

UK neighbors cut tree in half over bird poop dispute: ‘We were absolutely distraught’ Pictures of the odd tree in Sheffield, U.K., have been posted online and have been turned into memes on social media. via FOX NEWS https://ift.tt/3jl8Sk3

PM Modi lauds IFS officers for their work towards serving nation, furthering national interests https://ift.tt/36HoEzw

Greeting Indian Foreign Service officers on IFS day, Prime Minister Narendra Modi on Friday said that their work towards serving the nation and furthering national interests globally are commendable. Their efforts during the Vande Bharat Mission, which was launched to bring Indians home from abroad during the COVID-19 pandemic as international travel came to a halt, and other related help to our citizens and other nations is noteworthy, Modi added.